Biolingus IP GmbH

BioLingus is a Swiss biotech company spearheading the development of oral (sublingual) delivery of peptides and proteins for chronic diseases and immuno-therapy via our innovative formulation technology. Our company focuses on the development of products for treatment of metabolic diseases and various immuno-therapies.